Myomo (MYO) Cash from Operations Growth (1y) (2017 - 2025)
Powered by 
Analysis
Myomo (MYO) Cash from Operations Growth (1y) (2017 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 21.54% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 48.31% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 64.80% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 13.50% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 14.62% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 124.64% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 0.99% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -11.16% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -12.60% |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -22.40% |
| Jun 30, 2025 | -362.72% |
| Mar 31, 2025 | 17.52% |
| Dec 31, 2024 | 242.87% |
| Sep 30, 2024 | 12.87% |
| Jun 30, 2024 | -571.02% |
| Mar 31, 2024 | -78.65% |
| Dec 31, 2023 | 4.40% |
| Sep 30, 2023 | 38.73% |
| Jun 30, 2023 | 89.22% |
| Mar 31, 2023 | 21.78% |
| Dec 31, 2022 | -34.76% |
| Sep 30, 2022 | -26.66% |
| Jun 30, 2022 | 22.04% |
| Mar 31, 2022 | -9.93% |
| Dec 31, 2021 | -61.39% |
| Sep 30, 2021 | -23.50% |
| Jun 30, 2021 | 7.34% |
| Mar 31, 2021 | 13.59% |
| Dec 31, 2020 | 57.15% |